Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Á¦¾î ¹æÃâÇü ±Ù°ü ¼Òµ¶Á¦·ÎºÎÅÍ Å¬·Î¸£Çí½ÃµòÀÇ ¹æÃâ¿¡ ¹ÌÄ¡´Â 3°¡Áö POLYMERÀÇ Á¦¾îÈ¿°ú

The sustaining effect of three polymers on the release of chlorhexidine from a controlled release drug device for root canal disinfection

´ëÇÑÄ¡°úº¸Á¸ÇÐȸÁö 2004³â 29±Ç 6È£ p.548 ~ 554
¼Ò¼Ó »ó¼¼Á¤º¸
º¹¿µºó/Bok YB ÀÌ´ö¿¬/ÀÌÂù¿µ/±è°æ³²/±Ý±â¿¬/Lee DY/Lee CY/Kim KN/Kum KY

Abstract

º» ¿¬±¸´Â ¼­¹æÇü ±Ù°ü¼Òµ¶Á¦(CRD)ÀÇ prototypeÀ¸·Î ºÎÅÍ chlorhexidine (CHX) ÀÇ ¹æÃâ ¼Óµµ¸¦ Á¦¾îÇϱâ À§ÇÑ 3°¡Áö polymer (chitosan, PMMA, PLGA) ÀÇ Á¦¾î È¿°ú¸¦ Æò°¡Çϱâ À§ÇØ ÀÌ·ç¾îÁ³´Ù. 80¹ø paper point (Sure-Endo TM, #80)¿¡ 20% CHX¸¦ loading ÇÑ ÈÄ °¢ ±º´ç 10 °³¾¿ 4 ±ºÀ¸·Î ºÐ·ùÇÏ¿´´Ù; Croup A: Non-polymer coated prototype, Group B: chitosan-coated prototype, Group C: PMMA-coated prototype, Group D: PLGA-coated prototype. °¢°¢ÀÇ paper point¿¡ ÇÔÀ¯µÈ CHX¾çÀ» µ¿ÀÏÇÏ°Ô Çϱâ À§ÇØ, CHX loadingÈÄ ¹«°Ô¸¦ ÃøÁ¤ÇÏ¿© À¯»çÇÑ ¹«°ÔÀÇ sampleÀ» ¼±ÅÃÇÏ¿© »ç¿ëÇÏ¿´´Ù. ¸ðµç ½ÃÆíÀº 3mlÁõ·ù¼ö°¡ ´ã±ä Å¥ºª¿¡ ³ÖÀº ÈÄ 3, 6, 10, 20, 30,40, 50ºÐ ¸¶´Ù. 1, 2, 3,4, 5, 6½Ã°£ ¸¶´Ù °¢°¢ 10§¡¾¿ äÃëÇÏ°í, 1ÁÖÀÏ ÈÄ ´Ù½Ã 10§¡À» äÃëÇÏ¿© UVÈí±¤µµ¸¦ ÀÌ¿ëÇÏ¿© CHXÀÇ ¹æÃâ ¼Óµµ¸¦ ºñ±³ÇÏ¿´´Ù. ¶ÇÇÑ, °¢ prototypeÀÇ Ç¥¸é °üÂûÀ» À§ÇÏ¿© 100¹è¿Í 5000¹èÀÇ ÁÖ»çÀüÀÚ Çö¹Ì°æÀ» ÀÌ¿ëÇÏ¿© Ç¥¸é ±¸Á¶¸¦ ÃÔ¿µÇÏ¿´´Ù. 1. CHX ÀÇ ¹æÃâ ¼Óµµ´Â non-coated groupo, chitosan-coated group, PLGA-coated grouop, PMMA-coated group¼øÀ̾úÀ¸¸ç °¢ ±º°£¿¡´Â Åë°èÇÐÀû ÀÎ À¯ÀÇÂ÷°¡ ÀÖ¾ú´Ù (p < 0.05). 2. PMMA ³ª PLGA ¸¦ µµÆ÷ÇÑ CRD Ç¥¸é¿¡¼­¸¸ pore°¡ °üÂûµÇ¾úÀ¸¸ç pore size°¡ Ä¿Áú¼ö·Ï ¹æÃâ ¼Óµµ°¡ »¡¶ú´Ù. °á·ÐÀûÀ¸·Î polymer coating¿¡ ÀÇÇØ Á¦¾î¹æÃâÇü ±Ù°ü¼Òµ¶Á¦ÀÇ protoytype À¸·Î ºÎÅÍ ¾à¹° (CHX)ÀÇ ¹æÃâ ¼Óµµ¸¦ Á¦¾î ÇÒ¼ö ÀÖ¾ú´Ù.

The aim of this in vitro study was to evaluate the suitability of using chitosan, poly (lactide-co-glycolide) (PLGA), and polymethyl methacrylate (PMMA) to control the release of chlorhexidine diglucon ate (CHX) from a prototype of controlled release drug device (CRD) for root canal disinfection. Four different prototypes with different formulations were prepared. Group A (n = 12): The device (absorbent paper point) was loaded with CHX as control. Group B (n = 12): same as group A. but the device was coated with chitosan. In Groups C and D, the device was treated in the same way as group A and then coated three times with 5% PMMA (Group C, n = 12), or coated three times with 3% PLGA (Group D, n = 12). The devices were randomly allocated to experimental groups of 12 each. All CRD prototypes were soaked in 3 mL distilled water. The concentrations of CHX were determined using a UV spectrophotometer. The surface characteristics of each prototype were observed using a scanning electron microscope. The result showed that release rate of CHX was the greatest in the non-coated group, followed by the chitosan-coated group, the PLGA-coated group, and the PMMA-coated group (P < 0.05). Pores were observed on the surface of the prototypes that were coated with PLGA and PMMA. When the pore size was smaller, the release rate was lower. This data indicate that polymer coating can control the release rate of CHX from the CRD prototypes.

Å°¿öµå

Á¦¾î¹æÃâÇü ±Ù°ü¼Òµ¶Á¦;Ŭ·Î¸£Çí½Ãµò;Controlled release drug device;Chlorhexidine digluconate;Chitosan;Polymethyl methacrylate;Poly (lactide-co-glycolide);Root canal disinfectant

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI